Pure Global AI
NCT06316609Recruitment Completed

Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis

Prenatal Exposure to Emerging Contaminants and Offspring's Atopic Dermatitis (PECCAD)
Children's Hospital of Fudan UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Atopic Dermatitis
Drug/Device/Intervention
Gestational Exposure to Emerging Contaminants (ECs)
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Children's Hospital of Fudan University
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2016
End date
Dec 31, 2027
Enrollment
456 participants
Primary outcome

atopic dermatitis: Infant atopic dermatitis incidence

Summary

This prospective cohort study aims to investigate the association between prenatal blood
 levels of Emerging Contaminants and the five-year incidence of atopic dermatitis (AD) in
 offspring.

ICD-10 classifications
Atopic dermatitisAtopic dermatitis, unspecifiedOther atopic dermatitisAcute atopic conjunctivitisAllergic contact dermatitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06316609
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06316609 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Hospital of Fudan University and is currently Recruitment Completed. The study focuses on Atopic Dermatitis. Target enrollment is 456 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.